Loading…
Loading…
THCX (The Cannabis ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Green Thumb Industries is one of the few U.S. cannabis companies that has been consistently profitable. The company grew revenue and earnings in the second quarter.
Canopy Growth's cannabis business is showing signs of a turnaround, with revenue growth, improving margins and a narrower EBITDA loss fueling its rally.
Christina Lake signs non-binding LOI for a proposed $15M acquisition of all its shares, subject to due diligence, debt repayment and definitive agreement
Shares of Tilray Brands (NASDAQ:TLRY) are up 6% to $4.75 Wednesday afternoon, participating in a broad bid for beaten-down speculative names.
EDMONTON, AB, Aug. 19, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that it has acquired Internode Pharma Limited, a licensed importer and wholesaler, and HAP Pharma Limited, a licensed pharmacy (the "Companies"). "The acquisition of Internode Pharma Limited and HAP Pharma Limited mark a further strategic milestone for Aurora as we continue to purposefully invest in expanding our leadership in the rapidly growing international medical cannabis market.
TORONTO and GLIL YAM, Israel, Aug. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares, no par value per share ("Common Shares") on the basis of one post-consolidated Common Share for every thirty pre-consolidated Common Shares (the "Consolidation"). The Board has authorized the Consolidation to be effected on or before September 15, 2026, with the Company currently expecting August 27, 2026 to be the effective date of the Consolidation (the "Effective Date").
Canadian cannabis stocks are once again gaining attention as investors search for opportunities within the global marijuana industry. The sector has experienced significant changes since Canada legalized recreational cannabis in 2018. However, several leading companies have emerged stronger after years of restructuring, cost reductions, and increased competition.
Tenant default/restructuring pains have been mostly mitigated by NewLake Capital's four-wall strategy and focus on "credit-worthy cannabis tenants." These have contributed to the 100% rental collection, healthy balance sheet, and well-covered dividend payouts, underscoring their highly compelling cannabis REIT thesis. The discounted price/AFFO of 8.19x has contributed to NLCP's rich dividend yield of 10.83% and outsized upside potential to my bull-case price target of $31.10.